Спиронолактон для Женский тип выпадения волос

Q: Does Спиронолактон help with Женский тип выпадения волос?

Based on 45 studies with 6,441 participants, there is strong evidence from multiple clinical trials that Спиронолактон may support Женский тип выпадения волос management. Our evidence grade is A (Strong Evidence).

Q: How much Спиронолактон should I take for Женский тип выпадения волос?

Studies have used various dosages. A commonly studied range is 100-200 mg/day (prescription). Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Спиронолактон?

Reported side effects may include Menstrual irregularities, Breast tenderness, Hyperkalemia (elevated potassium levels), Dizziness and orthostatic hypotension. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Спиронолактон and Женский тип выпадения волос?

We rate the evidence as Grade A (Strong Evidence). This rating is based on 45 peer-reviewed studies with 6,441 total participants. The overall direction of effect is positive.

На основе 19 исследований (2 meta-analyses, 4 RCTs) с участием 5,743 участников. 16/19 исследований показывают положительные эффекты.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dspironolactone\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Итог

Spironolactone is strongly supported by research as an effective option that may help women with female pattern hair loss, with both oral and topical formulations showing benefits in clinical trials.

84% of studies show positive effects, including 4 RCTs focused on women
Both oral and topical formulations have demonstrated benefits
A dedicated meta-analysis confirms efficacy and safety in female pattern hair loss
Combination with minoxidil may offer enhanced results

Key Study Findings

Review

Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.

Dose: None или: None Outcome: None Эффект: None None

Популяция: women with androgenetic alopecia (female pattern hair loss)

Randomized Controlled Trial n=204 24 weeks Double-blind

Spironolactone versus Bicalutamide in female pattern hair loss: A randomised clinical trial.

Dose: Bicalutamide 50 mg/day; spironolactone 100 mg/day или: Spironolactone 100 mg/day Outcome: Hair density and shaft diameter change at 24 … Эффект: Frontal: +5.05 vs +3.13 hairs/cm2 (diff 1.92) P < 0.001 (frontal); P = 0.028

Популяция: Women 18-50 with Sinclair Grade II-V FPHL (India)

randomized controlled trial n=80 24 weeks Single-blind

Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment …

Dose: Group A: 1% topical spironolactone gel twice daily; Group B: 5% topical minoxidil gel twice daily или: Placebo Эффект: Both groups showed statistically significant improvement. Group A: 10 mild, 16 moderate, 2 excellent None

RCT n=48 24 weeks Double-blind

Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a …

Dose: Spironolactone 100 mg once daily или: Placebo Эффект: Terminal hair counts: 9.48 vs 5.32 hairs/cm2; hair diameter: 4.23 vs 2.96 μm; moderate-to-marked imp p=0.063 (terminal hair counts)

Randomized Controlled Trial n=240 520 weeks Open-label

Nutritional deficiencies after sleeve gastrectomy and Roux-en-Y gastric bypass at 10 years: secondary analysis of …

Dose: None или: Laparoscopic Roux-en-Y gastric bypass (LRYGB) Outcome: Nutritional deficiency prevalence at 10 years Эффект: Iron deficiency: LSG 14% vs LRYGB 41% p=0.017 (iron deficiency)

Популяция: Severely obese adults undergoing bariatric surgery

Review

Male and female pattern hair loss.

Dose: None или: Placebo Эффект: None None

Key Statistics

Исследования

6441

Участники

↑

Positive

Оценка

Referenced Papers

Spironolactone versus Bicalutamide in female pattern hair loss: A randomised clinical trial. Other

Clinical and experimental … 2026

Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments. Review

American journal of … 2026

Nutritional deficiencies after sleeve gastrectomy and Roux-en-Y gastric bypass at 10 years: secondary analysis of the SLEEVEPASS randomized clinical trial. RCT

The British journal … 2025 10 цитирований

Spironolactone reduces the risk of low-dose oral minoxidil-induced edema in women with female pattern hair loss. Other

Journal of the … 2025 3 цитирований

Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot … Other

International journal of … 2025 3 цитирований

Male and female pattern hair loss. Review

Australian prescriber 2025 2 цитирований

Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment. Other

Dermatology practical & … 2025 1 цитирований

Evaluation of the Efficacy and Safety of Topical Spironolactone versus Topical Minoxidil in the Treatment of Female Pattern Hair Loss: … Other

International journal of … 2025

Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs. Other

Frontiers in veterinary … 2024 15 цитирований

The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral … RCT

Journal of cosmetic … 2024 14 цитирований

Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies. Review

Journal of clinical … 2024 11 цитирований

Efficacy and safety of spironolactone versus bicalutamide in female pattern hair loss: A retrospective comparative study. Other

The Australasian journal … 2024 5 цитирований

Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management. Other

Archives of dermatological … 2024 4 цитирований

Inter-strain variability in responses to a single administration of the cannabidiol-rich cannabis extract in mice. Other

Food and chemical … 2024 1 цитирований

Improving efficacy and maintaining safety in the treatment of alopecia with low-dose oral minoxidil and spironolactone combination therapy: A retrospective … Other

JAAD international 2024 1 цитирований

The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis. Review

Cureus 2023 13 цитирований

Combination therapy in female pattern hair loss. Review

Journal of cosmetic … 2023 3 цитирований

Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension … Other

Journal of personalized … 2022 16 цитирований

Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: … Case Report

Frontiers in medicine 2022 14 цитирований

Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative … Other

PEC innovation 2022 11 цитирований

Spironolactone for treatment of female pattern hair loss. Other

Journal of the … 2020 43 цитирований

Spironolactone in dermatology: uses in acne and beyond. Review

Clinical and experimental … 2020 20 цитирований

Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind … Other

Dermatology practical & … 2020 10 цитирований

Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee. Meta-Analysis

The Journal of … 2019 101 цитирований

Androgens in women: Androgen-mediated skin disease and patient evaluation. Review

Journal of the … 2019 95 цитирований

Androgens in women: Hormone-modulating therapies for skin disease. Review

Journal of the … 2019 55 цитирований

Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies. Review

Breast cancer research … 2019 36 цитирований

Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow. Other

Polski merkuriusz lekarski … 2019 4 цитирований

Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Observational

International journal of … 2018 142 цитирований

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review. Review

International journal of … 2018 129 цитирований

Female pattern hair loss. Other

Australian journal of … 2018 8 цитирований

Interventions for female pattern hair loss. Meta-Analysis

The Cochrane database … 2016 18 цитирований

Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis. Review

The Medical clinics … 2015 66 цитирований

Evidence-based approach to cutaneous hyperandrogenism in women. Review

Journal of the … 2015 50 цитирований

Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy. Other

Journal of the … 2015 43 цитирований

Hair loss in women. Review

Clinical obstetrics and … 2015 9 цитирований

Female pattern hair loss. Review

Current problems in … 2015 8 цитирований

[Spironolactone in dermatological treatment. On and off label indications]. Other

Der Hautarzt; Zeitschrift … 2013 19 цитирований

Female pattern alopecia: current perspectives. Review

International journal of … 2013

Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. Review

The British journal … 2011 96 цитирований

Treatment of female pattern hair loss with the androgen receptor antagonist flutamide. Case Report

The Australasian journal … 2011 44 цитирований

Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss. Other

Dermatologic clinics 2010 80 цитирований

Use of spironolactone in dermatology. Review

Skinmed 2010 33 цитирований

Successful treatment of female-pattern hair loss with spironolactone in a 9-year-old girl. Case Report

The Australasian journal … 2009 31 цитирований

Hair loss in women. Review

Seminars in cutaneous … 2009 4 цитирований

Treating female pattern hair loss. Noticeable hair loss can be deeply distressing. Here are some medical treatments that may help. Other

Harvard women's health … 2009

A review of hormonal therapy for female pattern (androgenic) alopecia. Review

Dermatology online journal 2008

Treatment of female pattern hair loss with a combination of spironolactone and minoxidil. Case Report

The Australasian journal … 2007 32 цитирований

[The treatment of female pattern hair loss]. Review

Duodecim; laaketieteellinen aikakauskirja 2006

Evaluation and treatment of male and female pattern hair loss. Other

Journal of the … 2005 247 цитирований

Treatment of female pattern hair loss with oral antiandrogens. Other

The British journal … 2005 205 цитирований

Chronic telogen effluvium: a study of 5 patients over 7 years. Case Report

Journal of the … 2005 64 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

hairloss:: 100-200 mg/day (prescription)

Верхний предел: 200 mg/day (hair loss indication)

Дозировки, изученные в исследованиях

Дозировка	Длительность	Эффект	N
None	--	Neutral	--
Bicalutamide 50 mg/day; spironolactone 100 mg/day	24 weeks	Positive	204
Group A: 1% topical spironolactone gel twice daily; Group B: 5% topical minoxidil gel twice daily	24 weeks	Positive	80
Spironolactone 100 mg once daily	24 weeks	Positive	48
None	520 weeks	Positive	240
None	--	Positive	--
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi	16 weeks	Positive	45
4 g	--	Neutral	--

Лучшее время приёма: Once or twice daily with food; prescription required

Safety & Side Effects

Зарегистрированные побочные эффекты

⚠ Menstrual irregularities
⚠ Breast tenderness
⚠ Hyperkalemia (elevated potassium levels)
⚠ Dizziness and orthostatic hypotension
⚠ Frequent urination

Известные взаимодействия

● ACE inhibitors and ARBs (increased hyperkalemia risk)
● Potassium supplements and potassium-sparing diuretics (dangerous hyperkalemia)
● NSAIDs (may reduce diuretic effectiveness and increase kidney risk)
● Digoxin (spironolactone may increase digoxin levels)

Допустимый верхний уровень потребления: 200 mg/day (hair loss indication)

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Спиронолактон help with Женский тип выпадения волос?

Based on 45 studies with 6,441 participants, there is strong evidence from multiple clinical trials that Спиронолактон may support Женский тип выпадения волос management. Our evidence grade is A (Strong Evidence).

How much Спиронолактон should I take for Женский тип выпадения волос?

Studies have used various dosages. A commonly studied range is 100-200 mg/day (prescription). Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Спиронолактон?

Reported side effects may include Menstrual irregularities, Breast tenderness, Hyperkalemia (elevated potassium levels), Dizziness and orthostatic hypotension. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Спиронолактон and Женский тип выпадения волос?

We rate the evidence as Grade A (Strong Evidence). This rating is based on 45 peer-reviewed studies with 6,441 total participants. The overall direction of effect is positive.

Related Evidence

Другие ингредиенты для Женский тип выпадения волос

Minoxidil A Витамин D A Низкоуровневая лазерная терапия A Nutrafol A Со пальметто B

Спиронолактон для других состояний

Андрогенетическая алопеция A

Краткий вывод

Evidence Strength92%

High confidence

Разбор исследований

RCT (2)Meta (2)Other (41)

Сравнить альтернативы

Узнайте, как другие ингредиенты сравниваются при данном состоянии.

Посмотреть все ингредиенты для Женский тип выпадения волос

Узнать больше

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.